Century buys a startup, raises funding in cell therapy expansion
BioPharma
Brent Pfeiffenberger Bain Capital Life Sciences Dive Brief Century Therapeutics Clade Therapeutics Octagon Capital
Source: biopharmadive.com
📰 Superstring Capital News
Superstring Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Superstring Capital. Real-time updates on events, politics, business and more.
Zenas BioPharma raises $118m Series B round to advance pipeline
US-based immune therapy developer Zenas has significant operations in China.
Source: dealstreetasia.com
Zenas BioPharma Raises $118M in Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
China Digest: Sironax raises $200m Series B; Qiming leads $120m round in OriCell
With this, Sironax has raised over $300 million to date.
Abu Dhabi Abuz Aby United Arab Emirates Innovation Fund Abu Dhabi Investment Authority Oricell Therapeutics
Source: dealstreetasia.com
Sironax Announces Closing of $200 Million Series B Financing
/PRNewswire/ -- Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related...
Source: prnewswire.com
Sironax Closes $200M Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs
ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.
United States David Lockhart Vertex Pharmaceuticals Hunt Technology Ventures Alnylam Pharmaceuticals Osage University Partners
Source: medcitynews.com